1Alberti, KGMM (2005) The metabolic syndrome – a new worldwide definition. Lancet 366, 1059–1062.
2Reaven, GM (1988) Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37, 1595–1607.
3Eckel, RH, Grundy, SM & Zimmet, PZ (2005) The metabolic syndrome. Lancet 365, 1415–1428.
4Isomaa, B, Almgren, P, Tuomi, T, et al. (2001) Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24, 683–689.
5Wilson, PWF, D'Agostino, RB, Parise, H, et al. (2005) Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112, 3066–3072.
6Ford, ES, Giles, WH & Dietz, WH (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287, 356–359.
7Tillin, T, Forouhi, N, Johnston, D, et al. (2005) Metabolic syndrome and coronary heart disease in South Asians, African-Caribbeans and white Europeans: a UK population-based cross-sectional study. Diabetologia 48, 649–656.
8Weiss, R, Dziura, J, Burgert, TS, et al. (2004) Obesity and the metabolic syndrome in children and adolescents. New Engl J Med 350, 2362–2374.
9Bäckhed, F, Ley, RE, Sonnenburg, JL, et al. (2005) Host-bacterial mutualism in the human intestine. Science 307, 1915–1920.
10Cani, PD & Delzenne, NM (2009) The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Design 15, 1546–1558.
11Cani, PD & Delzenne, NM (2009) Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota. Curr Opin Pharmacol 9, 737–743.
12Ley, RE, Turnbaugh, PJ, Klein, S, et al. (2006) Microbial ecology: human gut microbes associated with obesity. Nature 444, 1022–1023.
13Ley, RE, Bäckhed, F, Turnbaugh, P, et al. (2005) Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A 102, 11070–11075.
14Turnbaugh, PJ, Ley, RE, Mahowald, MA, et al. (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027–1131.
15Bäckhed, F, Ding, H, Wang, T, et al. (2004) The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 101, 15718–15723.
16Salminen, S, Ouwehand, A, Benno, Y, et al. (1999) Probiotics: how should they be defined? Trends Food Sci Technol 10, 107–110.
17Goldin, BR & Gorbach, SL (2008) Clinical indications for probiotics: an overview. Clin Infect Dis 46, Suppl. 2, S96–S100.
18Ishibashi, N & Yamazaki, S (2001) Probiotics and safety. Am J Clin Nutr 73, 2 Suppl., 465S–470S.
19Ouwehand, AC & Salminen, SJ (1998) The health effects of cultured milk products with viable and non-viable bacteria. Int Dairy J 8, 749–758.
20He, F, Morita, H, Kubota, A, et al. (2005) Effect of orally administered non-viable Lactobacillus cells on murine humoral immune responses. Microbiol Immunol 49, 993–997.
21Kawase, M, He, F, Kubota, A, et al. (2006) Inhibitory effect of Lactobacillus gasseri TMC0356 and Lactobacillus GG on enhanced vascular permeability of nasal mucosa in experimental allergic rhinitis of rats. Biosci Biotechnol Biochem 70, 3025–3030.
22Kawase, M, He, F, Kubota, A, et al. (2009) Effect of fermented milk prepared with two probiotic strains on Japanese cedar pollinosis in a double-blind placebo-controlled clinical study. Int J Food Microbiol 128, 429–434.
23Naito, E, Yoshida, Y, Makino, K, et al. (2011) Beneficial effect of oral administration of Lactobacillus casei strain Shirota on insulin resistance in diet-induced obesity mice. J Appl Microbiol 110, 650–657.
24Lee, HY, Park, JH, Seok, SH, et al. (2006) Human originated bacteria, Lactobacillus rhamnosus PL60, produce conjugated linoleic acid and show anti-obesity effects in diet-induced obese mice. Biochim Biophys Acta 1761, 736–744.
25Tanida, M, Shen, J, Maeda, K, et al. (2008) High-fat diet-induced obesity is attenuated by probiotic strain Lactobacillus paracasei ST11 (NCC2461) in rats. Obes Res Clin Pract 2, 159–169.
26Ohlson, K, Mahlapuu, M & Svensson, U (2007) Probiotics to Influence Fat Metabolism and Obesity. WO Patent WO/2007/043,933..
27Parnell, JA & Reimer, RA (2009) Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am J Clin Nutr 89, 1751–1759.
28Delzenne, NM, Cani, PD, Daubioul, C, et al. (2007) Impact of inulin and oligofructose on gastrointestinal peptides. Br J Nutr 93, S157–S161.
29Yun, S, Park, H & Kang, J (2009) Effect of Lactobacillus gasseri BNR17 on blood glucose levels and body weight in a mouse model of type 2 diabetes. J Appl Microbiol 107, 1681–1686.
30Tabuchi, M, Ozaki, M, Tamura, A, et al. (2003) Antidiabetic effect of Lactobacillus GG in streptozotocin-induced diabetic rats. Biosci Biotechnol Biochem 67, 1421–1424.
31Yamano, T, Tanida, M, Niijima, A, et al. (2006) Effects of the probiotic strain Lactobacillus johnsonii strain La1 on autonomic nerves and blood glucose in rats. Life Sci 79, 1963–1967.
32Matsuzaki, T, Yamazaki, R, Hashimoto, S, et al. (1997) Antidiabetic effects of an oral administration of Lactobacillus casei in a non-insulin-dependent diabetes mellitus (NIDDM) model using KK-Ay mice. Endocr J 44, 357–365.
33Savransky, V, Nanayakkara, A, Li, J, et al. (2007) Chronic intermittent hypoxia induces atherosclerosis. Am J Resp Crit Care 175, 1290–1297.
34Jäkälä, P & Vapaatalo, H (2010) Antihypertensive peptides from milk proteins. Pharmaceuticals 3, 251–272.
35Cani, PD, Bibiloni, R, Knauf, C, et al. (2008) Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57, 1470–1481.
36Monteiro, R & Azevedo, I (2010) Chronic inflammation in obesity and the metabolic syndrome. Mediators Inflamm .
37Erridge, C, Attina, T, Spickett, CM, et al. (2007) A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr 86, 1286–1292.
38Buettner, R, Sch lmerich, J & Bollheimer, LC (2007) High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity 15, 798–808.
39Morita, H, He, F, Fuse, T, et al. (2002) Cytokine production by the murine macrophage cell line J774. 1 after exposure to lactobacilli. Biosci Biotechnol Biochem 66, 1963–1966.
40Suganami, T & Ogawa, Y (2010) Adipose tissue macrophages: their role in adipose tissue remodeling. J Leukoc Biol 88, 33–39.
41Miettinen, M, Vuopio-Varkila, J & Varkila, K (1996) Production of human tumor necrosis factor alpha, interleukin-6, and interleukin-10 is induced by lactic acid bacteria. Infect Immun 64, 5403–5405.
42Erickson, KL & Hubbard, NE (2000) Probiotic immunomodulation in health and disease. J Nutr 130, 2S Suppl., 403S–409S.